Zomedica Corp
ZOM
Get informed when a big investor buys or sells
+ FollowMarket Cap$95.35M
Close$
$-0.14
241% downside
Current Fair Value
241% downsideOvervalued by 241% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $95.35 Million |
|---|---|
| Enterprise Value | $86.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.08 |
| Beta | 1.16 |
| Outstanding Shares | 979,949,668 |
Return
| Return on Equity | -20.36% |
|---|---|
| Return on Assets | -18.58% |
| Return on Invested Capital | -29.32% |
Valuation & Multiples
| P/E Ratio | -4.22 |
|---|---|
| PEG | 4.55 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.53 |
| Enterprise Value to EBIT | -2.62 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 5, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zomedica Corp
19 employeesBased in Ann Arbor, Michigan, Zomedica is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will include innovative diagnostics and medi...